Cardiovascular and demographic characteristics in whole blood and plasma donors: Results from the Donor InSight study

Transfusion

Volumn 51, Issue 2, 2011, Pages 412-420

  Atsma, Femke ^a   Veldhuizen, Ingrid ^a   De Vegt, Femmie ^a   Doggen, Carine ^a   De Kort, Wim ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD DONOR; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; LIFESTYLE; MALE; MARRIAGE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR;

ADULT; AGED; ALCOHOL DRINKING; BLOOD DONORS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS; EDUCATIONAL STATUS; ETHNIC GROUPS; FAMILY HEALTH; FEMALE; HEALTH SURVEYS; HUMANS; LIFE STYLE; LIPIDS; MALE; MARRIAGE; MIDDLE AGED; MOTIVATION; MOTOR ACTIVITY; NETHERLANDS; NUTRITIONAL STATUS; PLASMA; QUESTIONNAIRES; REPRODUCTIVE HISTORY; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 79951594446     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02867.x     Document Type: Article

References (49)

1. Greinacher A, Fendrich K, Alpen U, Hoffmann W,. Impact of demographic changes on the blood supply: Mecklenburg-West Pomerania as a model region for Europe. Transfusion 2007; 47: 395-401.
2. Currie CJ, Patel TC, McEwan P, Dixon S,. Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service. Transfus Med 2004; 14: 19-24. (Pubitemid 38477755)
3. Zou S, Musavi F, Notari EP, Fang CT,. Changing age distribution of the blood donor population in the United States. Transfusion 2007; 48: 251-7.
4. Zuck TF, Thomson RA, Schreiber GB, Gilcher RO, Kleinman SH, Murphy EL, Ownby HE, Williams AE, Busch MP, Smith JW,. The Retrovirus Epidemiology Donor Study (REDS): rationale and methods. Transfusion 1995; 35: 944-51. (Pubitemid 26141048)
5. Ameratunga SN, Norton RN, Whitlock G, Macmahon S, Coggan C, Jackson RT, Langley JD, Parag V, Smith D, Woodfield DG,. The New Zealand Blood Donors' Health Study: baseline findings of a large prospective cohort study of injury. Inj Prev 2002; 8: 66-9.
6. Veldhuizen IJT, Doggen CJM, Atsma F, De Kort WLAM,. Donor profiles: demographic factors and their influence on the donor career. Vox Sang 2009; 97: 129-38.
7. Burnett JJ,. Psychographic and demographic characteristics of blood donors. J Consum Res 1981; 8: 62-6.
8. Condie S, Maxwell N,. Comparative demographic profiles: voluntary and paid blood donors. Transfusion 1970; 10: 84-8.
9. Boulware LE, Ratner LE, Ness PM, Cooper LA, Campbell-Lee S, LaVeist TA, Powe NR,. The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public. Transfusion 2002; 42: 669-78.
10. Hollingsworth B, Wildman J,. What population factors influence the decision to donate blood? Transfus Med 2004; 14: 9-12. (Pubitemid 38477753)
11. Edgren G, Tran TN, Hjalgrim H, Rostgaard K, Shanwell A, Titlestad K, Wikman A, Norda R, Jersild C, Wideroff L, Gridley G, Adami J, Melbye M, Nyrén O, Reilly M,. Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion 2007; 47: 2017-24. (Pubitemid 47623971)
12. Vaartjes I, van Dis SJ, Peters RJG, Visseren FLJ, Bots ML,. Hart- en vaatziekten in Nederland naar geslacht. In:, Vaartjes I, Peters PJG, van Dis SJ, Bots ML, editors. Hart- en vaatziekten in Nederland 2008, cijfers over ziekte en sterfte. Den Haag: Nederlandse Hartstichting; 2008.
13. Salonen JT, Tuomainen TP, Salonen R, Lakka TA, Nyyssonen K,. Donation of blood is associated with reduced risk of myocardial infarction. The kuopio ischaemic heart disease risk factor study. Am J Epidemiol 1998; 148: 445-51. (Pubitemid 28411101)
14. Tuomainen TP, Salonen R, Nyyssonen K, Salonen JT,. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ 1997; 314: 793-4. (Pubitemid 27117051)
15. Commission of the European Communities. Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components. Official Journal European Union, L91, 2004. p. 25-39.
16. Gordon T, Kannel WB,. Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. Am Heart J 1982; 103: 1031-9. (Pubitemid 13137891)
17. Kannel WB, McGee DL,. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979; 2: 120-6. (Pubitemid 9238733)
18. Murray RP, Connett JE, Tyas SL, Bond R, Ekuma O, Silversides CK, Barnes GE,. Alcohol volume, drinking pattern, and cardiovascular disease morbidity and mortality: is there a U-shaped function? Am J Epidemiol 2002; 155: 242-8. (Pubitemid 34117302)
19. Philips B, de Lemos JA, Patel MJ, McGuire DK, Khera A,. Relation of family history of myocardial infarction and the presence of coronary arterial calcium in various age and risk factor groups. Am J Cardiol 2007; 99: 825-9. (Pubitemid 46365607)
20. Arsenault BJ, Rana JS, Lemieux I, Despres JP, Wareham NJ, Kastelein JJ, Boekholdt SM, Khaw KT,. Physical activity, the Framingham risk score and risk of coronary heart disease in men and women of the EPIC-Norfolk study. Atherosclerosis 2010; 209: 261-5.
21. Jenkins PV, O'Donnell JS,. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion 2006; 46: 1836-44. (Pubitemid 44435738)
22. Wu O, Bayoumi N, Vickers MA, Clark P,. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 62-9.
23. Statistics Netherlands. Statline [Data File]. Heerlen/Voorburg, The Netherlands; 2008.
24. Hoogendoorn EH, Hermus AR, de Vegt F, Ross HA, Verbeek AL, Kiemeney LA, Swinkels DW, Sweep FC, den Heijer M,. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 2006; 52: 104-11. (Pubitemid 43032473)
25. Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M,. Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 2007; 72: 632-7. (Pubitemid 47312796)
26. Murphy EL, Shaz B, Hillyer CD, Carey P, Custer BS, Hirschler N, Fang J, Schreiber GB,. Minority and foreign-born representation among US blood donors: demographics and donation frequency for 2006. Transfusion 2009; 49: 2221-8.
27. Grassineau D, Papa K, Ducourneau A, Duboz P, Boetsch G, Chiaroni J,. Improving minority blood donation: anthropologic approach in a migrant community. Transfusion 2007; 47: 402-9.
28. Veldhuizen I, Folléa G, Degiorgio A, Bart T, Fontana S, Tschaggelar A, Lévy G,. Donor recruitment. In:, de Kort W, Veldhuizen I, editors. Donor management manual. 1st ed. Nijmegen, The Netherlands: 2010. p. 84-102.
29. Shaz BH, Demmons DG, Hillyer KL, Jones RE, Hillyer CD,. Racial differences in motivators and barriers to blood donation among blood donors. Arch Pathol Lab Med 2009; 133: 1444-7.
30. Newman BH, Satz SL, Janowicz NM, Siegfried BA,. Donor reactions in high-school donors: the effects of sex, weight, and collection volume. Transfusion 2006; 46: 284-8. (Pubitemid 43381767)
31. Newman BH,. Vasovagal reaction rates and body weight: findings in high- and low-risk populations. Transfusion 2003; 43: 1084-8. (Pubitemid 37022368)
32. France CR, Rader A, Carlson B,. Donors who react may not come back: analysis of repeat donation as a function of phlebotomist ratings of vasovagal reactions. Transfus Apher Sci 2005; 33: 99-106. (Pubitemid 41329875)
33. Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R, Bingham S, Khaw KT, Wareham NJ,. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 2007; 50: 949-56. (Pubitemid 46559245)
34. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB,. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004; 291: 711-7. (Pubitemid 38543791)
35. Tuomainen TP, Diczfalusy U, Kaikkonen J, Nyyssonen K, Salonen JT,. Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man. Free Radic Biol Med 2003; 35: 922-8. (Pubitemid 37211446)
36. Fargion S, Dongiovanni P, Guzzo A, Colombo S, Valenti L, Fracanzani AL,. Iron and insulin resistance. Aliment Pharmacol Ther 2005; 22 Suppl 2: 61-3. (Pubitemid 41564386)
37. Aigner E, Datz C,. Iron perturbations in human non-alcoholic fatty liver disease (NAFLD): clinical relevance and molecular mechanisms. Hepatitis Mon 2008; 8: 213-20.
38. Fernandez-Real JM, Lopez-Bermejo A, Ricart W,. Iron stores, blood donation, and insulin sensitivity and secretion. Clin Chem 2005; 51: 1201-5. (Pubitemid 43079398)
39. Guillygomarc'h A, Mendler MH, Moirand R, Laine F, Quentin V, David V, Brissot P, Deugnier Y,. Venesection therapy of insulin resistance-associated hepatic iron overload. J Hepatol 2001; 35: 344-9. (Pubitemid 32844188)
40. Piperno A, Vergani A, Salvioni A, Trombini P, Vigano M, Riva A, Zoppo A, Boari G, Mancia G,. Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome. Liver Int 2004; 24: 471-6. (Pubitemid 40484562)
41. Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, Vanni E, Fargion S,. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol 2007; 102: 1251-8. (Pubitemid 46802029)
42. Tuomainen TP, Punnonen K, Nyyssonen K, Salonen JT,. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998; 97: 1461-6. (Pubitemid 28191301)
43. Engberink MF, Geleijnse JM, Durga J, Swinkels DW, de Kort WL, Schouten EG, Verhoef P,. Blood donation, body iron status and carotid intima-media thickness. Atherosclerosis 2008; 196: 856-62. (Pubitemid 351146657)
44. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ,. Blood donations and risk of coronary heart disease in men. Circulation 2001; 103: 52-7. (Pubitemid 32050435)
45. Meyers DG, Jensen KC, Menitove JE,. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion 2002; 42: 1135-9.
46. Meyers DG, Strickland D, Maloley PA, Seburg JK, Wilson JE, McManus BF,. Possible association of a reduction in cardiovascular events with blood donation. Heart 1997; 78: 188-93. (Pubitemid 27404957)
47. Glynn SA, Schreiber GB, Busch MP, Kleinman SH, Williams AE, Nass CC, Ownby HE, Smith JW,. Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: a comparison of apheresis and whole-blood donors. The Retrovirus Epidemiology Donor Study. Transfusion 1998; 38: 350-8. (Pubitemid 28213590)
48. Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, Nass CC, Williams AE,. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000; 284: 229-35. (Pubitemid 30460868)
49. Glynn SA, Smith JW, Schreiber GB, Kleinman SH, Nass CC, Bethel J, Biswas B, Thomson RA, Williams AE,. Repeat whole-blood and plateletpheresis donors: unreported deferrable risks, reactive screening tests, andresponse to incentive programs. Transfusion 2001; 41: 736-43. (Pubitemid 32538506)